Free CME from PeerView


Allergy & Immunology CME

PVI, PeerView Institute for Medical Education
Taking the Pulse of Undiagnosed Atrial Fibrillation: Pharmacists as a Lynchpin of Detection and Team-Based Care
May 06, 2022
Medical Learning Institute, Inc.
Making Sense of New Standards for CLL: Pharmacist Insights on Targeted Therapy and the Delivery of Team-Based Care
May 06, 2022
PVI, PeerView Institute for Medical Education
Tackling the Challenge of Treating Severe Asthma: Taking Aim at the Airway Epithelium
May 04, 2022
PVI, PeerView Institute for Medical Education
Addressing the Burden of Prurigo Nodularis: Expert Insight on Disease Pathogenesis and the Clinical Potential of Novel Therapeutic Options
April 28, 2022
PVI, PeerView Institute for Medical Education
Sharing the Cure: Best Practices for Primary Care Providers to Improve HCV Prevention, Care, and Treatment
April 21, 2022
PVI, PeerView Institute for Medical Education
New Evidence on Cardiac Myosin Inhibition in Hypertrophic Cardiomyopathy: Analysis From Washington, DC
April 20, 2022
Medical Learning Institute, Inc.
Making the Case for Preventing and Managing Nephropathy in Patients With Fabry Disease
April 19, 2022
Medical Learning Institute, Inc.
Expanding the Benefits of PARP Inhibitors to More Patients With Breast Cancer and Earlier Settings
April 08, 2022
Medical Learning Institute, Inc.
Solving the Challenge of Tumor Lysis Syndrome: Expert Insight and Guidance on a Challenging Oncologic Emergency
April 04, 2022
Medical Learning Institute, Inc.
Recent Advances in the Management of Depressive Disorders: Preparing for a Shift in the Treatment Paradigm
March 31, 2022
PVI, PeerView Institute for Medical Education
Primary Care Call to Action for VTE Management: Sharpening Skills in Recognition, Treatment, and Secondary Prevention
March 31, 2022
Medical Learning Institute, Inc.
Rationale, Evidence, and Practical Potential for BTK Inhibitors in Patient-Centered MS Care: Where We Stand Now
February 26, 2022

Pages